Gene · 3269
Papers3,179
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,179
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synergistic cell membrane-coated ECL-DNA biosensor for specificity-enhanced drug lead evaluation. | J Pharm Anal | 2026 | 41716474 | PubTator, text mining | PubMed |
| Enthalpy-Entropy Trade-Off Underlies Geometric Isomer Selectivity in Histamine H1 Receptor-Doxepin Interaction. | ACS Med Chem Lett | 2026 | 41704352 | PubTator, text mining | PubMed |
| Potential salivary protein biomarkers for the identification of mild traumatic brain injury: A systematic review. | Adv Clin Exp Med | 2026 | 41698173 | PubTator, text mining | PubMed |
| Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H1 receptor. | RSC Med Chem | 2026 | 41695591 | PubTator, text mining | PubMed |
| ENDOSOMAL SIGNALING OF PROTEASE-ACTIVATED RECEPTOR-2 AMPLIFIES HISTAMINE-INDUCED PAIN OF IRRITABLE BOWEL SYNDROME. | bioRxiv | 2026 | 41676509 | PubTator, text mining | PubMed |
| Dose-Dependent Effect of the Histamine 1 Receptor Antagonist Ebastine in Patients With Non-Constipated Irritable Bowel Syndrome. | Neurogastroenterol Motil | 2026 | 41603723 | PubTator, text mining | PubMed |
| Heat stress in dairy buffalo: biometeorological, molecular, and adaptive strategies for climate change resilience in subtropical regions. | Vet Res Commun | 2026 | 41543626 | PubTator, text mining | PubMed |
| Optical control of H1 receptor signaling with a BODIPY-photocaged antihistamine. | Biochem Pharmacol | 2026 | 41539494 | PubTator, text mining | PubMed |
| Characterization of Human Group 9 Innate Lymphoid Cells in Response to Allergen Immunotherapy in Patients With Allergic Rhinitis. | Allergy | 2026 | 41451507 | PubTator, text mining | PubMed |
| Activity-restoring mutations in the histamine H3 receptor increase constitutive activity and reduce structural stability. | Protein Sci | 2026 | 41427659 | PubTator, text mining | PubMed |
| Evaluation of photochemical behavior of ebastine and elucidation of its photoproducts. | J Pharm Biomed Anal | 2026 | 41344120 | PubTator, text mining | PubMed |
| Madecassoside-functionalized platinum-based liposomes for sensitive skin: Enhancing rapid soothing and barrier homeostasis. | Colloids Surf B Biointerfaces | 2026 | 41273894 | PubTator, text mining | PubMed |
| Bioequivalence Study of Two Olopatadine Hydrochloride Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions. | Clin Pharmacol Drug Dev | 2026 | 41253596 | PubTator, text mining | PubMed |
| Network toxicology and machine learning reveal key molecular targets and pathways of mono-2-ethylhexyl phthalate-induced atherosclerosis. | Drug Chem Toxicol | 2026 | 41250617 | PubTator, text mining | PubMed |
| Impact of Desloratadine on Treatment Response and Inflammation During Neoadjuvant Chemotherapy in Stage II-III Breast Cancer: A Randomized Pilot Study. | Arch Med Res | 2026 | 41223739 | PubTator, text mining | PubMed |
| Determination of enantiomerization barriers of desloratadine and its N-oxide derivative by dynamic enantioselective high-performance liquid chromatography and off-column racemization experiments. | J Pharm Biomed Anal | 2026 | 41014884 | PubTator, text mining | PubMed |
| Histamine induces vascular endothelial cell proliferation via the histamine H1 receptor-extracellular regulated protein kinase 1/2-cyclin D1/cyclin-dependent kinase 4/6 axis. | Microvasc Res | 2026 | 40912453 | PubTator, text mining | PubMed |
| Molecular docking analysis of phytoconstituents from Nilavaagai Chooranam with histamine H1 receptor. | Bioinformation | 2025 | 41623849 | PubTator, text mining | PubMed |
| The Histamine-Associated Inflammatory Landscape of Endometriosis: Molecular Profiling of HDC, HRH1-HRH4, and Cytokines Across Lesion Subtypes. | Int J Mol Sci | 2025 | 41516088 | PubTator, text mining | PubMed |
| Azelastine Inhibits Triple-Negative Breast Cancer Cell Viability via an ARF1-Dependent Mechanism. | Int J Mol Sci | 2025 | 41465279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3269/papers?page=3